Epidemiological Profile and Mortality of Infective Endocarditis Over the Past Decade: A Systematic Review and Meta-Analysis of 133 Studies

Andreas Tzoumas(Aristotle University of Thessaloniki), Leonidas Palaiodimos(Albert Einstein College of Medicine), Grigorios Korosoglou(University of Mannheim), Μarios Sagris(National and Kapodistrian University of Athens), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Ioannis Kyriakoulis(University of Thessaly), Wasla Liaqat(Albert Einstein College of Medicine), Athina Ntoumaziou(Cincinnati Children's Hospital Medical Center), Sanjana Nagraj(Jacobi Medical Center), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Dimitris Tousoulis(National and Kapodistrian University of Athens), Dimitrios Xenos(Hippocration General Hospital), Fotis Kakargias(Aristotle University of Thessaloniki)
The American Journal of Cardiology
February 25, 2025
10.1016/j.amjcard.2025.02.023
Cited by 17

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|734
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|586